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Abstract 
ESPOSITO, TYLER   Localization of the follicle-stimulating hormone receptor in lipid raft 
domains. Department of Biological Sciences, June 2014. 
 
ADVISOR: Professor Brian Cohen 
 Lipid raft domains have been shown to be important in receptor signaling, especially for 
G Protein Coupled Receptors (GPCR).  Follicle stimulating hormone is a vital reproductive 
signal that relies on effective signaling of its GPCR.  The goal of this study was to test whether 
or not the follicle stimulating hormone receptor (FSHR) utilizes lipid raft domains when 
signaling. 
 The main methods used were fluorescent antibodies and various forms of microscopy, 
including confocal microscopy.  A fluorescent antibody for the FSHR (mAb 106.105) allowed us 
to perform these studies. 
 In the first experiment, cells treated with FSH and stained with the receptor antibody 
showed aggregation of receptors.  This supported the belief that FSHR are clustering in lipid raft 
domains when signaling.  Next nystatin, a lipid raft disrupting chemical, was used to show that if 
the lipid rafts were disturbed, this clustering of receptor would not be observed.  In these trials 
the cells treated with FSH looked similar to the cells that received no treatment.  Finally we used 
the Cholera Toxin B subunit to fluorescently tag lipid raft domains, while still staining for 
receptor.  This showed colocalization of the receptor and lipid rafts in cells treated with FSH and 
those who did not receive treatment (but at a lower intensity). 
 These results support the hypothesis that FSHR utilizes lipid rafts when signaling, most 
likely to improve signaling efficiency.  
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Introduction: 
 Any animal's most basic evolutionary need is to survive and reproduce.  Fertility, the 
ability of an organism to reproduce, is vital to the continuation of a species.  Experiments and 
studies concerned with fertility range from hoping to cure infertility to working on birth control.  
In a world where over-population of certain animals and massive extinction of others has become 
a serious issue for society, finding new ways to affect fertility has become necessary to conserve 
natural resources at a viable level.  There is no denying the importance of studying reproduction 
and the systems that regulate this process. 
 The endocrine system plays a major role in regulating the ability of mammals to 
reproduce.  Hormones are regulatory biochemicals that are transported through the bloodstream 
to a specific part of the body and produce a result (Hanley & Holt, 2007).  Most hormone 
signaling involves a signal traveling from the hypothalamus to the anterior pituitary, where it 
signals for the release of another molecule, which travels to the target tissue where it has an 
effect.  The anterior pituitary is made up of distinct types of cells that are involved in different 
signaling pathways.  Ten to fifteen percent of the cells in the anterior pituitary are gonadotrophs.  
The gonadotrophs are basophils, named for their ability to take up basic stains.  These cells 
secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which are 
gonadotrophins (Hanley & Holt, 2007). 
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 Follicle-stimulating hormone (or follitropin) is released from the anterior pituitary in 
response to gonadotropin releasing hormone (GnRH) signaling from the hypothalamus (Hanley 
& Holt, 2007).  FSH is a 32 kDa heterodimeric glycoprotein (Dias et al., 2002) consisting of an 
alpha and a beta subunit (figure 1).  Release of this dimeric glycoprotein is negatively regulated 
by stress, prolactin, as well as inhibin (Holt & Hanley, 2007).  FSH travels to the testes in men or 
the ovaries in women (Holt & Hanley 2007).  Follicle-stimulating hormone and its receptor are 
necessary for proper and normal gamete maturation in both males and females (Dias et al., 
2002).  In males, FSH stimulates spermatogenesis and gonadal maturation by binding to its 
receptor on Sertoli cells in the testis (Holt & Hanley, 2007).  In females, FSH binds to its 
receptor on granulosa cells and signals for the development of ovarian follicles and eggs (Dias, et 
al., 2002).  It is used as a supplement in females to help with the chance of pregnancy and in 
males to increase sperm count (Dias et al., 2002).  Issues with FSH or its receptor can lead to 
delayed or precocious (accelerated) puberty, hypogonadism, fertility issues, and many other 
reproductive problems (Holt & Hanley, 2007). 
 
Figure 1. Ribbon diagram of follicle stimulating hormone, which shows the α and β subunits. 
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 The follicle stimulating hormone receptor (FSHR) is a vital part of this system.  If the 
receptor is not functioning properly, this signaling pathway will be incapable of producing any 
change in the target cells.  The FSHR is a G protein coupled (GPCR) which is found on the 
surface of Sertoli cells of the testis (males) and granulosa cells of the ovaries (females) (Dias, et 
al., 2002).  FSHR have a seven alpha-helical transmembrane domain and contain a large 
extracellular domain which is used to bind the glycoprotein ligand, FSH (Dias, et al., 2002).   
The FSHR is highly conserved among species.  FSH binds to the large extracellular domain of 
the receptor in a hand clasp fashion as seen in figure 2 (Fan & Hendrickson, 2005).  When 
bound, FSH undergoes a conformational change which plays a part in receptor activation.  The 
ligand activated receptors utilize G proteins as secondary signaling molecules, and initiates 
downstream signaling cascades which eventually changes gene expression in these cells, which 
results in a specific effect (i.e. granulosa cell differentiation in females). 
 
Figure 2. Ribbon diagram of FSH bound to the extracellular domain of the FSHR.  The FSH α 
chain is shown in green and the FSH β chain is in blue.  The FSHR is red (Fan & Hendrickson, 
2005). 
 When FSH binds to its receptor it has the eventual consequence of "sustaining ovarian 
follicle growth in females and spermatogenesis in males" (Telikicherla et al., 2011).  In order 
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accomplish this result; FSH binding must initiate multiple downstream signaling pathways.  The 
main downstream pathway begins, after hormone binding with, the activation of the 
heterodimeric G-protein (Gs).  This protein converts GTP into GDP over a span of time which 
allows the response of the hormone binding is controlled.  This activation causes an increase in 
adenylate cyclase activity, and production of cyclic AMP (cAMP).  The increase in cAMP 
causes activation of protein kinases, which phosphorylate multiple transcription factors.  These 
transcription factors regulate expression of FSH-target genes.  FSH binding to its receptor also 
activates other secondary messengers, in addition to cAMP, including calcium and IP3.  This 
process causes a total of 265 genes to be regulated (Telikicherla et al., 2011). 
 Luteinizing hormone, FSH and their respective receptors have many similarities.  
Luteinizing hormone is also a glycoprotein and a gonadotropin which binds to an extracellular 
receptor.  Like FSH, LH is secreted by the anterior pituitary and is the other hormone mainly 
responsible for proper reproductive maturity of gametes.  Both hormones rely on G protein 
coupled receptors.  These receptors are similar in that they both have the seven trans-membrane 
region and a large extracellular domain, with multiple motifs in common in these structures 
(Simoni et al. 1997) (figure 3). 
 
Image 3. Structure of the FSH receptor.  Displays the seven transmembrane region and the large 
extracellular domain.  LH receptor is very similar. 
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 A study by Roess et al. showed convincing evidence that the LHR aggregates in lipid raft 
domains when signaling.  When viewing electron micrographs of rat granulosa cells this group 
noticed that when LH was present and binding to its receptor, the receptors would aggregate 
quickly in pockets on the plasma membrane.  The ability of these receptors to go from being 
diffuse across the plasma membrane to aggregating in pockets after minutes caused this group to 
question whether these receptors were grouped in arbitrary areas or in specific microdomains 
like lipid rafts.   Also, it was known that many G protein coupled receptors have been shown to 
utilize lipid raft domains for signaling; including the Gonadotropin Releasing Hormone, 
Somatostatin, and Adenosine receptors (Chini & Parenti, 2004).  This led to the hypothesis that 
the LHR is aggregating in lipid raft domains when signaling.  Roess et al. showed convincing 
evidence that their hypothesis is correct using sucrose gradients.  The receptor was found in high 
density portions of the gradient, representative of bulk membrane fractions, before ligand was 
added.  Following the addition of a ligand the receptor was found in low density fractions, 
representative of lipid rafts.  The results of this study and the many similarities between FSH and 
LH were important in the formation of our hypothesis. 
 All mammalian cells contain lipid raft microdomains as a part of their plasma membrane, 
so these components must be significant (Insel & Ostrom, 2004).  Lipid rafts are enriched with 
lipid and proteins.  More specifically, lipid rafts are characterized by high levels of sphingolipids 
and cholesterol.  This makes them more ordered than the normal phospholipid membrane (Chini 
& Parenti, 2004).  These domains are important for the compartmentation of certain receptors; 
especially G protein coupled receptors.  In a typical signaling system there is a low concentration 
of signaling molecules and receptors but a rapid response to hormones is observed.  One 
hypothesis to explain this is that the cell concentrates its signaling molecules in these lipid raft 
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microdomains (Isnel & Ostrom, 2004).  Lipid rafts have been shown to be important for the fine-
tuning of the cell signaling machinery located on the cell surface (Chini & Parenti, 2004).  The 
fact that activation of FSHR specifically activates the Gs protein is important.  Certain studies 
have shown that Gs and Gi proteins localize in lipid rafts (Insel and Ostrom, 2004).  These G-
proteins have an affinity for an ordered lipid environment (Moffet, et al., 2000).  As previously 
discussed, the ability of the FSHR to signal relies on this protein to begin the downstream 
signaling cascade, and to do so in a controlled manner.  The high concentration of G proteins 
could increase the efficiency of signaling.  This is one explanation as to why this receptor may 
move into these microdomains when signaling.  Another explanation is that these domains 
increase the efficiency of GPCR internalization (Insel, et al., 2005). 
 Some G protein coupled receptors are always found in lipid rafts (Bradykinin and 
Dopamine).  Some move out of lipid rafts when an agonist is present (Oxytocin).  Others have 
the ability to move in and out of lipid raft domains upon activation (GnRH and Growth Hormone 
Releasing Hormone) (Insel, et al., 2005).  Therefore, there must be some determinant which 
causes this movement.  Some have hypothesized that it involves the extracellular domain of the 
receptor, others believe it involves the transmembrane domain and its interaction with 
cholesterol, finally some think this process involves the intracellular loops and carboxylic by 
protein-protein interaction and fatty acylation (Chini & Parenti, 2004).  These different 
hypotheses have been shown to be important for receptor localization in lipid rafts/caveolae, in 
different circumstances. 
 Studies have shown that the relationship between GPCRs and lipid raft/caveolae is 
variable between cell types, the type of receptor, the metabolic state of the cell and other factors.  
This fact clouds our understanding of this relationship and makes it difficult to make any 
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generalizations concerning it.  It is clear, however, that when researching a GPCR, the role of 
lipid rafts in the process of signaling, endocytosis, etc is an important question to understand.  As 
scientists continue to investigate individual receptors and how they utilize raft domains, our 
knowledge of lipid rafts will inherently grow substantially.  Our hypothesis is that these signals 
should be colocalized and overlap if the receptor is in a lipid raft domain.  The knowledge of 
when FSHR resides in lipid rafts could have medical implications, as well as add to our 
recognition of the importance of lipid rafts in GPCR signaling. 
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Methods: 
Most current techniques to study lipid rafts involve cell lysates and fractionation studies which 
destroy the morphology of the cell and rely on biochemical assays and reagents.  While these 
types of studies have a valuable purpose, studying compartmentation of receptors on the plasma 
membrane of a cell is best studied using microscopy because it is a morphological phenomena 
(Insel & Ostrom, 2004).  Using a technique where the cell can be observed directly without 
affecting its morphology is desired.  This is difficult because even the use of fluorescent markers 
have a slight effect on cell morphology (Insel & Ostrom, 2004).  Despite this fact, using 
microscopy is preferred over the other techniques which involve lysing the cells.  Recently the 
use of fluorescent antibodies to tag proteins (i.e. receptors) and putative raft markers have been 
utilized to image colocalization between proteins and rafts (Conn, 2013).  This technique has had 
great success.  This effectively avoids affecting the cells’ morphology, but is not with some 
pitfalls.  Any technique "requiring labeling, protein or raft/nonraft marker membrane 
localization/organization might be influenced by their labels" (Conn, 2013).  This technique will 
be used to add more evidence to answer if the FSHR is found in lipid raft domains of human 
granulosa cells, and not as a lone method to prove anything on its own.  This is the technique that 
we used to study the colocalization of the FSHR in lipid rafts.  The use of the confocal 
microscope was vital for the proper imaging of the cells. 
 Knowledge of the contents of lipid rafts allowed researchers to develop techniques to 
create putative markers for lipid raft domains.  The most common tag used is the Cholera toxin B 
(CTxB) subunit which binds to the ganglioside GM1 found only in lipid rafts in cells.  Groups 
have used this technique to test for colocalization of receptors in lipid rafts and if lipid rafts are 
important for the internalization and intracellular trafficking of the signal (Drake, et al., 2003).  
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The ganglioside GM1 can be observed with a fluorescently modified CTxB subunit (image 4).  
This allows for visualization of lipid raft domains in live cells which are usually too small to be 
seen using microscopy.  The FSHR can also be tagged with a specific monoclonal antibody and a 
fluorescent antibody to visualize the receptor's location on the same cell.  This technique will be 
used to test for localization of the FSHR in lipid rafts domains, with or without treatments of 
FSH.   
 Using fluorescently labeled CTxB is a relatively new technique that has been used with 
success.  It avoids using detergent lysates and fractionation techniques that involve destroying 
the cell.  It is not a perfect system however.  The binding of the CTxB subunit to the lipid rafts 
will inherently alter the location of these domains on the membrane.  The fact that we will be 
comparing the cells with no treatment with cells that have been treated with FSH helps to limit 
this disadvantage.  Any differences between these conditions will presumably be because of the 
treatment and not the CTxB.  Also further studies will be carried out utilizing completely 
different techniques (co-immunoprecipitation) to support or disprove the results of these 
experiments. 
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Image 4. Ribbon structure of the cholera toxin b subunit (above).  Below that is a depiction of a 
lipid raft domain of a plasma membrane with the ganglioside GM1 highlighted.  The structure of 
the ganglioside GM1 including the area where CTxB binds and the membrane anchor labeled is 
shown on the right (Peterson, 2005). 
 The early testing of this hypothesis required the ability to disrupt lipid rafts.  Nystatin is a 
polyene antibiotic and also a cholesterol sequestering agent.  This is an effective research tool 
because, "cholesterol sequestration alters composition of the plasma membrane micro-
organization (lipid rafts)" (Baek, et al., 2013).  Using treatments of nystatin allowed us to test 
whether the loss of stable, normal, lipid raft domains would cause significant changes in the 
staining of receptor when bound by its ligand (actively signaling). 
 Being able to culture and use immortalized human granulosa cells was imperative for this 
study.  HGrC1 cells were used for the staining procedures.  These cells are representative of the 
granulosa cells in the ovaries.  They express the FSHR in a physiologically relevant level, and 
therefore signal in response to FSH treatments.   
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 The hope of this research is to test whether FSHR utilizes lipid raft domains when 
signaling.  The use of antibodies for the receptor (mAb 106.105) and the lipid raft marker 
antibody (Cholera Toxin B kit) allow us to check for colocalization using microscopy.  The 
antibody was provided by Professor James Dias of SUNY Albany.  By using hormone treatments 
of variable lengths we hoped to learn more concerning the mobility of the receptor.  The use of 
specific antibodies makes this research possible and allows for straightforward visualization of 
the result.  It avoids many pitfalls of other lab procedures that typically involve lysing the cell.   
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Cell Culture  
HGrC1 cell line was cultured and used for all experiments (Bayasula, et al., 2012).  This cell line 
is human granulosa cells and express a physiologically relevant number of follicle-stimulating 
hormone receptor (FSHR). We choose this cell line so that we could effectively stain for FSHR.  
This avoided an over-expression of receptor, or the need to transfect a receptor gene into a 
different cell line. 
Growing Cells on Cover Slips 
Coverslips were sterilized and then placed into a well of a Falcon 6 well plate.  Added 0.5 ml of 
0.1 mg/ml Poly-D-lysine to each well and let sit for 10 minutes, to promote cell adhesion.  Next 
the wells were washed with sterile water and then allowed to dry for 1 hour.  At this point the 
cells were split and added to the wells. 
Treatments 
The newly split cells were allowed to grow and become confluent.  When confluent, the cells 
could be stained for FSHR using fluorescent antibodies.  First, one hour prior to staining, if there 
was any nystatin treatment it was carried out (5µg nystatin/1ml of serum free medium/well).  If 
there was any FSH treatment needed it would be performed directly before the fluorescent 
staining (either 30, 15 or 5 minutes, before staining).  The cells would be washed with 2 ml of 
serum free medium and then treated with FSH dissolved in serum free medium (40ng FSH/2ml 
of serum free medium/well) for the desired amount of time. 
Staining Cells 
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Next, the cells were washed with PBS.  Cells were fixed in 400 µl of paraformaldehyde (PFA) 
for 30 minutes and then the wells were washed with PBS.  Next, they were blocked with 1 ml of 
1% BSA in 1x PBS for one hour.  Then 250 µl of the primary antibody (mAb 106.105) was 
added to each well at a dilution of 1:200 with 1% BSA and 1x PBS.  This was left to incubate 
overnight at 4°C.  The following day the wells were washed with PBS and then stained with 
secondary antibody (Goat-anti-mouse-alexa 594) at a dilution of 1:500 with 1% BSA and 1x 
PBS.  This incubated for 1 hour, before the wells were washed a final time with PBS.  A drop of 
ProLong antifade reagent or fluorogel was added to microscope slides.  Flourogel was used in 
the first experiment and allowed for DAPI staining.  DAPI stains the nucleus with a blue stain.  
The later experiments were carried out with ProLong, which effectively seals the slide and 
prevents fading of the fluorescence, while still staining for DAPI.  Each coverslip was placed 
face down on the drop of ProLong/fluorogel and the bubbles were removed.  The slides were 
allowed to dry at room temperature in a dark area for 24 hours. 
Cholera Toxin B  
The V-34403 Vybrant Alexa Flour 488 Lipid Raft Labeling Kit was purchased for this project.  
This kit allowed us to stain for lipid raft domains using the protocol provided with the kit.  It was 
performed after any FSH treatment but prior to staining for the FSHR.  The cholera toxin B 
(CTxB) subunit is added first with a fluorescent marker added with it, while the wells are on ice.  
Next the CtxB conjugate is added which cross-links the labeled lipid rafts into distinct patches on 
the plasma membrane (Vybrant-protocol).  At this point the staining for the FSHR would be 
done as described above. 
Imaging 
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Results of the fluorescent staining were imaged using an immuno-fluorescent microscope or a 
confocal microscope.  Both microscopes allowed for imaging of both fluorescent signals and 
allowed for a "merge" of these images to show if the signals were colocalized.  The confocal 
allowed for "series" imaging.  This showed cross-sectional cuts through the cell, which gave 
images of both signals from one side of the cell all the way to the other side.  This was an 
advantage for comparing the images and being able to visualize what is happening throughout 
the plasma membrane, not just on one side.  The Leica confocal imaging microscope and 
program was used to complete this imaging. 
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Results: 
Fluorescent Staining of FSHR on HGrC1 cells 
Initially, the staining for FSHR with treatments of FSH showed that our antibodies worked 
effectively to image the location and distribution of the FSHR.  The receptor was imaged using 
the red fluorescent antibody and the nucleus was blue (due to DAPI staining).  The staining 
showed that FSHR was diffuse across the membrane when no ligand was present; when no 
signaling is occurring, no aggregation of receptor was observed.  When exposed to FSH for 30 
minutes the cells showed clear aggregation of receptor on the plasma membrane.  Not all cells 
showed signs of strong aggregation.  Those that did display grouping showed variable levels of 
aggregation.  The 15 minute treatment and 5 minute treatment showed subtler grouping of 
receptor along the plasma membrane.  The images displayed below are representative of the 
patterns observed of each treatment (Figure 5).  These projects relied on a large number of 
images being compiled in order to fairly compare each treatment.  These "typical" pictures show 
the trend that was observed.  Extreme cases were also observed.  A cell with receptors that 
aggregated at a high level is shown below, as an example of how these treatments varied, and 
also because it emphasizes the fact that this aggregation is occurring (Figure 6). 
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Figure 1. Top Left.  No FSH treatment.  Top Right. 5 minute FSH treatment.  Bottom Left. 15 
minute FSH treatment. Bottom Right.  30 minute FSH treatment. 
 
Figure 2. Cell treated with FSH for 30 minutes and then stained for FSHR in red and DAPI 
staining in blue.  This shows extreme aggregation of receptor. 
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Nystatin Treatments 
Following that result, we carried out the same staining with treatments of FSH, but prior to 
staining we treated the cells with nystatin.  Again FSHR was stained for using a red fluorescent 
antibody.  Nystatin was effective in disrupting the formation of these aggregations in the 30 
minute FSH treated cells.  The staining of these cells shows receptor is spread over the plasma 
membrane in a diffuse fashion.  These cells looked very similar to the cells that were not treated 
with FSH.  The loss of aggregation of the FSHR in the nystatin treated cells was consistent and 
repeated.  As in the previous experiment, the images below are representative of the many 
images taken and trials completed of this experiment (Figure 3). 
 
 
Figure 3. Top. HGrC1 cells treated for 30 minutes with FSH and stained for FSHR.  Bottom.  
HGrC1 cells treated with nystatin, then FSH for 30 minutes, and stained for FSHR. 
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Cholera Toxin B Staining 
Using the confocal microscope images and "series" type videos were taken of the HGrC1 cells 
stained for FSHR and the lipid raft marker (using CTxB).  These images showed undeniable 
colocalization of FSHR and lipid rafts in all of the FSH treated cells.  The receptor was stained 
using a red fluorescent antibody, and the lipid raft antibody (CTxB) had a green fluorescent 
marker.  Colocalization of these two signals resulted in areas of yellow.  Any red or green 
observed was a sign of these two signals not being colocalized.  All three treatments of FSH 
showed colocalization of the two signals throughout the plasma membrane.  The cells treated for 
30 minutes had the most consistent colocalization of these two signals, but it varied from cell to 
cell.  The cells treated for 5 minutes and 15 minutes also displayed strong colocalization.  The 
results of the no FSH treatment cells were not as clean.  Two trials were completed.  In the first 
trial the cells that did not receive the FSH treatment showed clearly less colocalization than the 
treated cells.  In the second trial more colocalization was observed, and these cells appeared 
similar to the cells who received treatment.  These results show colocalization of the FSHR and 
the lipid raft when signaling and when no ligand is present (Figure 4).  No quantification or 
statistics could be carried out on this visual data, because of software limitations.  Despite the 
lack of quantification, there was an observable increase in colocalization after hormone was 
added. 
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Figure 4. Top Left. No FSH treatment, marginal colocalization.  Top Right. Treated with FSH 
for 5 minutes, shows colocalization. Bottom Left. Treated with FSH for 15 minutes, shows 
colocalization.  Bottom Right. Treated with FSH for 30 minutes, shows strong colocalization. 
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Discussion 
 The goal of this project was to address was whether FSHR utilizes lipid raft domains 
when signaling.  The results discussed above show convincing visual evidence of colocalization 
of the FSHR in lipid rafts.  The early experiments show the rationale for the use of cholera toxin 
B, which had been shown to be very effective in other studies.  Initial staining for FSHR and 
treating with FSH show very subtle and unremarkable differences in staining in most cases.  
There was however certain cells that showed clear aggregation and this, similar to the Roess, et 
al. study, lead us to believe that our receptor may be aggregating in lipid raft domains when 
signaling (Roess, et al., 2006).  This is more likely than the receptors aggregating in random 
areas because of the knowledge that LHR and other G protein coupled receptors group in lipid 
raft domains when actively signaling (Roess, et al., 2006, Chini & Parenti, 2004).   
 The cells which were treated with nystatin and FSH resulted in receptors that displayed 
diffuse staining.  This loss of aggregation is evidence that the lipid raft disrupting drug is 
effectively hindering the aggregation of FSHR.  This was the first evidence that the FSHR is in 
fact grouping in lipid raft domains and not arbitrarily on the membrane.  While the evidence 
shown is convincing, it is difficult to compare these pictures and come to definite conclusions 
because the differences between the images are very minute and vary slightly from cell to cell.  
The dissatisfaction with these results caused us to look for a different technique to effectively 
test our hypothesis. 
 The benefits of using cholera toxin B have been discussed and this was our next strategy.  
This staining effectively showed colocalization of the FSHR and lipid rafts during signaling.  In 
the cells not treated with FSH there was some colocalization observed but there was a pattern 
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that the treated cells generally had more colocalization.  This is visual data which relies on a 
comparison based on slight differences in staining.  These antibodies work effectively, so the 
signals are fairly strong.  This makes it even more difficult to make significant conclusions as to 
the movement of the receptor when signaling, compared to when not.  However, these results 
show evidence that the FSHR utilizes lipid raft domains.  Whether the FSHR moves into lipid 
raft domains at a significant amount, when signaling, is not supported or refuted by these results 
statistically.  If the colocalization of these signals could be calculated and quantified, and 
statistics could be carried out, it would allow us to make more conclusions concerning the 
kinetics of the receptor's interaction with lipid rafts.  These results do so strong localization with 
and without treatment which strongly supports the fact that lipid rafts are important for FSHR 
signaling. 
 This study shows a line of evidence supporting the hypothesis that FSHR aggregates in 
lipid raft domains when signaling.  Using various microscopy techniques we were able to stain 
for receptor and compile evidence that supported the initial hypothesis.  Further work concerning 
the quantification of the cholera toxin b staining results could lead to even more interesting 
conclusions.   
 Further studies with cholera toxin B would also be useful.  We have shown colocalization 
after treatment with FSH when the cells are stained and fixed after 30, 15 or 5 minutes.  It would 
be interesting to see if the FSHR was given time to signal, the FSH had dissipated, and the cell 
was back in normal conditions, if this colocalization is lost.  Perhaps if we tested FSH treatments 
for 60 minutes or 120 minutes and then stained using both the FSHR antibody and the CTxB kit, 
we could learn how long it takes the receptor to move out of the lipid raft domains after signaling 
has ended.   Although I focused on microscopy and fluorescent antibodies, other members of my 
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research team used very different techniques including co-immunoprecipitation, and transfection 
of a GFP-labeled lipid raft marker.  These projects showed similar results, which support the 
results of this study.   
 If the cells treated with nystatin are unable to effectively signal when FSH is present it 
would further support the importance of lipid rafts in the downstream signaling of this GPCR.  
We have shown that nystatin is effective in disrupting the aggregation of FSHR, but from this 
study it cannot be concluded as to whether this loss of aggregation affects the FSH signaling.  
However this would be a logical assumption to make, because this receptor would not aggregate 
when signaling unless there was some advantage to doing so. 
 The approach of using fluorescent antibodies and microscopy allowed us to view the 
location of the receptor without disturbing or destroying the cells.  Also the relatively short 
amount of time needed for each experiment allowed us to compile a large number of images.  
This library of images can continue to grow in future experiments and be interpreted further 
using new software, and compared with new research.  This was effective for testing our 
hypothesis, but the lack of quantification leaves the study with a certain amount of unmet 
potential.  Despite this downfall, this study has shown considerable empirical evidence that 
FSHR aggregates in lipid raft domains when signaling. 
 If the FSHR relies on lipid rafts to effectively signal, which this research supports, it 
would allow for new therapeutic strategies.  Medications that affect the lipid raft domains in the 
gonads specifically could be used to affect fertility.  The composition of these microdomains is 
known; therefore cholesterol sequestering drugs or similar medications could be modified to fit 
this purpose.  It could also be a new developmental explanation for infertility.  Some people may 
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have ample amounts of functioning receptors, but if these receptors rely on lipid rafts, and their 
cells lack lipid rafts in sufficient numbers they may not have mature gametes.  These would be 
interesting consequences along with further evidence of the importance of lipid raft domains in 
cell signaling.  
Esposito, 25 
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